Bromocriptine versus levodopa in early Parkinson's disease-Reference-Cited by-同舟云学术

Bromocriptine versus levodopa in early Parkinson's disease

Published:2007-10-17 Issue:1 Volume:2009 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van Hilten ¹,Ramaker Claudia C¹,Stowe Rebecca²,Ives Natalie²

Affiliation:

1. Leiden University of Medical Center; Department of Neurology; Albinusdreef 2 Leiden Netherlands 2333 ZA

2. University of Birmingham; University of Birmingham Clinical Trials Unit; Division of Medical Sciences, Robert Aitken Institute Edgbaston Birmingham UK B15 2TT

Publisher

Wiley

Subject

Pharmacology (medical)

Reference44 articles.

1. The Sydney multicentre study of Parkinson's disease: The first 18 months;Hely;The Medical Journal of Australia,1987

2. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years;Hely;Journal of Neurology, Neurosurgery, and Psychiatry,1989

3. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing with low dose bromocriptine with low dose levodopa-carbidopa;Hely;Journal of Neurology, Neurosurgery, and Psychiatry,1994

4. Long term bromocriptine treatment in de novo Parkinsonian patients;Herskovits;Medicina (B Aires),1988

5. A randomized blinded study of low-dose bromocriptine versus low-dose carbidopa/levodopa in untreated Parkinson's patients;Olanow,1987

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tremor-Dominant Form of Parkinson’s Disease;Neuroscience and Behavioral Physiology;2024-07

2. Tremor-dominant form of Parkinson’s disease;S.S. Korsakov Journal of Neurology and Psychiatry;2024

3. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22

4. Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus;Environmental Science and Pollution Research;2022-04-29

5. Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies;Tremor and Other Hyperkinetic Movements;2022